Futropha
Team
Dr. Tillman U. Gerngross, Thayer faculty
Dr. Jesse D. McCool, Thayer faculty
Mary Kay Brown, MS, Thayer and Pharmacology Dept.
Maaza Mehzun ’04
Grant Henderson TH’07
Company Overview
Futropha has developed a proprietary antibody production platform based on a bacterium called Ralstonia eutropha. This expression platform offers a unique method of antibody production that is inherently more cost-effective and scalable than current production methods. We aim to use this novel technology to provide antibodies to biotechnology companies for preclinical and clinical research.